A technology for cancer therapies that harnesses the immune system with nanoscale droplets suspended in an emulsion and delivered through the nose received a U.S. patent. . . . → Read More: Patent Awarded for Nasal Delivered Cancer Immunotherapy
|
|||||
 Comments are closed  Intellectual property  biomedical, biotechnology, cancer, equity, investment, licensing, life sciences, materials science, nanotechnology, patent, pharmaceuticals, physical sciences, university The fundamental difference between small business owners and employees vs. investors and big business owners is that the small business owner and employee are both trading time for money in a very linear and transactional way. . . . → Read More: Investing – The Path To True Wealth 
The U.S. Food and Drug Administration authorized marketing of software to help diagnose wrist fractures using machine-learning algorithms to read and interpret X-ray images. . . . → Read More: FDA Okays A.I.-Guided Wrist Fracture Software Comments are closed New products, Regulations biomedical, engineering, equity, FDA, investment, life sciences, mathematics, medical device, physical sciences, software 
In a report this week, our friends at CB Insights note that the investment community is waiting for graphene to reach a critical commercial mass, but their patience may be running out. . . . → Read More: Infographic – Graphene Investment in Decline One comment - (Comments are closed) Finance engineering, entrepreneurs, equity, investment, materials science, nanotechnology, physical sciences, U.K., venture capital 
A company is getting underway to develop therapies that extend genome editing to repair genetic disruptions, not just remove them from DNA. . . . → Read More: Genetic Repair Company Starts-Up, Gains $87 Million 2 comments - (Comments are closed) Finance, Intellectual property biomedical, biotechnology, entrepreneurs, equity, genomics, investment, licensing, life sciences, pharmaceuticals, university, venture capital 
Biotechnology company Genentech is licensing a process from a start-up enterprise that discovers small molecule drugs from naturally occurring microbes found in soil. . . . → Read More: Genentech Gains Microbe Drug Discovery Tech in $1B Deal Comments are closed Intellectual property biomedical, biotechnology, chemistry, entrepreneurs, equity, genomics, investment, licensing, life sciences, pharmaceuticals, physical sciences, university, venture capital 
One indicator of Google’s expanding involvement in health care is its venture investments in digital health and health technology start-ups, which is this weekend’s infographic. . . . → Read More: Infographic – Google Health Care Investments Take Off Comments are closed Finance biomedical, engineering, investment, life sciences, software, venture capital 
A start-up enterprise is discovering therapies to address a variety of disorders that result from faulty cell degradation processes known as autophagy, which when functioning normally contribute to cell health. . . . → Read More: New Cell Therapy Company Raises $58.5M in Early Funds Comments are closed Finance biomedical, biotechnology, entrepreneurs, equity, investment, life sciences, pharmaceuticals, university, venture capital 
A company using artificial intelligence algorithms and big data analytics to discover drug targets from RNA splicing errors is the winner of a competition among start-up enterprises for innovative uses of A.I. technology. . . . → Read More: Digital Drug Discovery Company Wins A.I. Competition 2 comments - (Comments are closed) Finance biomedical, engineering, equity, genomics, investment, life sciences, mathematics, medical device, physical sciences, software The realm of investing offers plenty of exciting opportunities for investors of all backgrounds. Here are five of the most pertinent aspects to consider. . . . → Read More: Intelligent Investments For Inexperienced Individuals: 5 Questions You Need To Ask |
One Blood Test Fits All Diseases A Thinking Person’s Artificial Intelligence Do You Want Your Bacon CRISPR? Health Care, Precisely One Person at a Time Let Guinea Pigs be Guinea Pigs Look Out Pharma. The Tech Industry is After You |
||||
|
Copyright © 2018 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
